Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 2
1(33.3%)
Phase 3
1(33.3%)
N/A
1(33.3%)
3Total
Phase 2(1)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06213649Phase 3Recruiting

Parasitic Ulcer Treatment Trial

Role: collaborator

NCT07463027Not ApplicableEnrolling By Invitation

Veteran's Interdisciplinary Care for Traumatic Brain Injury and Co-Occurring Disorders Rehabilitation Trial

Role: collaborator

NCT07325500Phase 2Recruiting

Incretin Microdosing for Cardiometabolic Health in People With HIV

Role: collaborator

All 3 trials loaded